Evidence map›Paper›PMID 28842826›Full record

ArticleMolecular neurobiology2018

Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway.

Harkaitz Bengoetxea, Irantzu Rico-Barrio, Naiara Ortuzar, Ane Murueta-Goyena, José V Lafuente

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Harkaitz BengoetxeaLaboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain. harkaitz.bengoetxea@ehu.eus.
Irantzu Rico-BarrioDepartment of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain.
Naiara OrtuzarLaboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain.
Ane Murueta-GoyenaLaboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain.
José V LafuenteLaboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain.
University of the Basque Country · ESUniversidad Autónoma de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure to an enriched environment (EE) has neuroprotective benefits and improves recovery from brain injury due to, among other, increased neurotrophic factor expression. Through these neurotrophins, important cortical and hippocampal changes occur. Vandetanib acts as a tyrosine kinase inhibitor of cell receptors, among others, the vascular endothelial growth factor receptor (VEGFR). Our aim was to investigate the effectiveness of EE counteracting cognitive and cellular effects after tyrosine kinase receptor blockade. Animals were reared under standard laboratory condition or EE; both groups received vandetanib or vehicle. Visuospatial learning was tested with Morris water maze. Neuronal, interneuronal, and vascular densities were measured by inmunohistochemistry and histochemistry techniques. Quantifications were performed in the hippocampus and in the visual cortex. Brain-derived neurotrophic factor (BDNF), tyrosine kinase B receptor (TrkB), Akt, and Erk were measured by Western blot technique. Vandetanib produces a significant decrease in vascular and neuronal densities and reduction in the expression of molecules involved in survival and proliferation processes such as phospho-Akt/Akt and phospho-Erk/Erk. These results correlated to a cognitive impairment in visuospatial test. On the other hand, animals reared in an EE are able to reverse the negative effects, activating PI3K-AKT and MAP kinase pathways mediated by BDNF-TrkB binding. Present results provide novel and consistent evidences about the usefulness of living in EE as a strategy to improve deleterious effects of blocking neurotrophic pathways by vandetanib and the notable role of the BDNF-TrkB pathway to balance the neurovascular unit and cognitive effects.

Indexed as

EnvironmentAnimalsBrain-Derived Neurotrophic FactorProtein Kinase InhibitorsProtein-Tyrosine KinasesRatsRats, Long-EvansReceptor, trkBSignal TransductionBdnf protein, ratBrain-Derived Neurotrophic FactorNtrk2 protein, ratProtein Kinase InhibitorsProtein-Tyrosine KinasesReceptor, trkBEnriched environmentHippocampusNeuroprotectionNeurotrophinsTyrosine kinase inhibitorVisual cortex

Identifiers

PMID28842826
OpenAlexW2746735285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.